| 臺大學術典藏 |
2020-09-30T03:22:29Z |
Virological response to tenofovir disoproxil fumarate in HIV-positive patients with Lamivudine-resistant hepatitis b virus coinfection in an area hyperendemic for Hepatitis B Virus Infection
|
Huang Y.-S.; Chang S.-Y.; Sheng W.-H.; Sun H.-Y.; Lee K.-Y.; Chuang Y.-C.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:28Z |
Long-term durability of responses to 2 or 3 doses of hepatitis a vaccination in human immunodeficiency virus-positive adults on antiretroviral therapy
|
Cheng A.; Chang S.-Y.; Sun H.-Y.; Tsai M.-S.; Liu W.-C.; Su Y.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:27Z |
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
|
Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Hsiao C.-F.; Chiang C.; Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Chiang C.;Hsiao C.-F.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:27Z |
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy
|
Chen Y.-C.; Chang S.-C.; CHIEN-CHING HUNG; Chang S.-Y.; Jhong Y.-T.; Sun H.-Y.; Wang J.-T.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Wu U.-I. |
| 臺大學術典藏 |
2020-09-30T03:22:27Z |
Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: A cross-sectional questionnaire survey
|
Lee Y.-C.; Chang S.-Y.; Lin K.-Y.; Chang L.-H.; Liu W.-C.; Wu C.-H.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Tsai M.-S.; Chang S.-Y.; Lin S.-W.; Kuo C.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2020-09-30T03:22:24Z |
Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination
|
Chen G.-J.; Lin K.-Y.; Sun H.-Y.; Sheng W.-H.; Hsieh S.-M.; Huang Y.-C.; Cheng A.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:24Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H.; Hsieh S.-M.; Sheng W.-H.; Liu C.-H.; Sun H.-Y.; Liu C.-J. |
| 臺大學術典藏 |
2020-09-30T03:22:23Z |
Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination
|
Lin K.-Y.; Cheng A.; Sun H.-Y.; Chen G.-J.; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:22Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2020-09-30T03:22:21Z |
Performance of fracture risk assessment tool in HIV-positive male individuals aged ?45?years on suppressive antiretroviral therapy
|
Tsai M.-S.; Zhang J.-Y.; Sun H.-Y.; Liu W.-C.; Wu P.-Y.; Yang C.-J.; CHIEN-CHING HUNG; Tsai M.-S.;Zhang J.-Y.;Sun H.-Y.;Liu W.-C.;Wu P.-Y.;Yang C.-J.;Chien-Ching Hung |
| 臺大學術典藏 |
2020-09-30T03:22:19Z |
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients
|
Liu W.-C.; CHIEN-CHING HUNG; Huang Y.-C.; Su Y.-C.; Chen G.-J.;Sun H.-Y.;Chang S.-Y.;Cheng A.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; Huang Y.-S.; Lin K.-Y. |
| 臺大學術典藏 |
2020-09-30T03:22:19Z |
Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy
|
Chen G.-J.;Sun H.-Y.;Cheng A.;Chuang Y.-C.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Liu W.-C.;Wu P.-Y.;Chien-Ching Hung;Chang S.-C.; Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:19Z |
Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection
|
Huang Y.-S.;Sun H.-Y.;Chang S.-Y.;Chuang Y.-C.;Cheng A.;Huang S.-H.;Huang Y.-C.;Chen G.-J.;Lin K.-Y.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:18Z |
Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan
|
Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:17Z |
Hepatitis E Virus Infections Among Human Immunodeficiency Virus–Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan
|
Chang S.-Y.; Liu W.-C.; Lin K.-Y.; Lin P.-H.; Sun H.-Y.; Chen Y.-T.; Su L.-H.; Su Y.-C.; Ho S.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:17Z |
HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan
|
Huang M.-H.;Chang S.-Y.;Liu C.-H.;Cheng A.;Su L.-H.;Liu W.-C.;Su Y.-C.;Sun H.-Y.;Chien-Ching Hung;Chang S.-C.; Huang M.-H.; Chang S.-Y.; Liu C.-H.; Cheng A.; Su L.-H.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:16Z |
Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study
|
Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C. |
| 臺大學術典藏 |
2020-09-30T03:22:16Z |
Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression
|
Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Ou S.-T.; Lin S.-W.; Huang W.-C.;Huang C.-K.;Huang S.-H.;Lin S.-W.;Ou S.-T.;Chen Y.-T.;Chen Y.-W.;Chang S.-Y.;Liu W.-C.;Sun H.-Y.;Chien-Ching Hung; Huang W.-C.; Huang C.-K.; Huang S.-H. |
| 臺大學術典藏 |
2020-09-30T03:22:15Z |
Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
|
Kuo P.-H.;Sun H.-Y.;Chuang Y.-C.;Wu P.-Y.;Liu W.-C.;Chien-Ching Hung; Kuo P.-H.; Sun H.-Y.; Chuang Y.-C.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:13Z |
Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011–2018
|
Ho S.-Y.; Su L.-H.; Sun H.-Y.; Huang Y.-S.; Chuang Y.-C.; Huang M.-H.; Liu W.-C.; Su Y.-C.; Lin P.-H.; Chang S.-Y.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-29T01:47:35Z |
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy
|
Wu U.-I.; Hung C.-C.; Chang S.-Y.; Jhong Y.-T.; Sun H.-Y.; Wang J.-T.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Chang S.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-08-21T07:43:12Z |
HBV DNA level as an important determinant of E antigen seroconversion of chronic hepatitis B during Adefovir dipivoxil therapy
|
Wu I.-C.; CHIN-KUO CHANG; Chou A.-L.; Liu W.-C.; Chang T.-T.; Tseng K.-C.; Cheng P.-N. |
| 臺大學術典藏 |
2020-08-06T07:51:52Z |
Reduced bone mineral density among HIV-infected patients in Taiwan: Prevalence and associated factors
|
TIFFANY TING-FANG SHIH; Tsai M.-S.; Hung C.-C.; Liu W.-C.; Chen K.-L.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Sun H.-Y. |
| 臺大學術典藏 |
2020-07-24T08:58:31Z |
Seasonal and daily climate variation have opposite effects on species elevational range size
|
Huang, C.-Y .; Shen, S.-F.; SHENG-FENG SHEN; Liu, W.-C .; Chan, W.-P .;Chen, I.-C .;Colwell, R.K .;Liu, W.-C .;Huang, C.-Y .;Shen, S.-F.; Chan, W.-P .; Chen, I.-C .; Colwell, R.K . |
